Quantitative membrane proteomics reveals new cellular targets of viral immune modulators
about
HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradationThe great escape: viral strategies to counter BST-2/tetherinThe formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to VpuEvolutionary history and attenuation of myxoma virus on two continentsBST2/Tetherin enhances entry of human cytomegalovirusSpecies-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherinStructural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomainThe UBAP1 subunit of ESCRT-I interacts with ubiquitin via a SOUBA domainBroad-spectrum inhibition of retroviral and filoviral particle release by tetherinHIV-1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanismsDifferential effects of human immunodeficiency virus type 1 Vpu on the stability of BST-2/tetherinBST-2/tetherin: a new component of the innate immune response to enveloped virusesAntiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteractionVpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanismMolecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirusThe role of BST-2/Tetherin in host protection and disease manifestationKSHV: pathways to tumorigenesis and persistent infectionDirect restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particlesStructural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformationsAberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cellsApplication of proteomics to soft tissue sarcomasHaploid genetic screens identify an essential role for PLP2 in the downregulation of novel plasma membrane targets by viral E3 ubiquitin ligasesInterferon-induced tetherin restricts vesicular stomatitis virus release in neuronsHSV-2 glycoprotein gD targets the CC domain of tetherin and promotes tetherin degradation via lysosomal pathwayCounteraction of the multifunctional restriction factor tetherinThe interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu proteinRemodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus.BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infectionMembrane-Associated RING-CH proteins associate with Bap31 and target CD81 and CD44 to lysosomes.Ultra structural characterisation of tetherin - a protein capable of preventing viral release from the plasma membraneEndothelial cells support persistent gammaherpesvirus 68 infection.Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variantsMutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion.Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking.CAML does not modulate tetherin-mediated restriction of HIV-1 particle releaseThe RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherinCharacterization of E3 ligases involved in lysosomal sorting of the HIV-1 restriction factor BST2.Antiviral activity of the interferon-induced cellular protein BST-2/tetherin.BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (nsP1)
P2860
Q21089617-AFD53283-19C7-4D88-A08B-81EDC5E1B729Q21090506-64FA8B46-641C-4EB4-9CE4-ED566704AB71Q21245050-EBE3F56F-CBFB-427E-AC64-CDCF2A057881Q21558784-F2A9C5AA-8AC1-446C-90E9-3B422D1B69F9Q21559401-D2754B1F-1452-41D4-9107-F145DE93DD14Q21559418-53BB138F-A02F-4CED-BE21-BF1F1697EEFFQ24294470-450366B8-3520-486C-A8F4-6F18E1AEFFF5Q24306855-78D3F929-3B1B-42BD-A8BE-4C7D2961A518Q24306898-B4DE18E0-D872-4C69-85B7-D793447E8991Q24318564-6A71DD1C-AD8E-4171-8A53-50E170F2BE5FQ24619066-0CB65C3F-9068-4035-9891-D23BA56F32EEQ24629504-20909D3E-163C-4CED-8D9D-A65202E353ABQ24630382-0A1D7DC9-22D7-4247-8017-FA2E5699D594Q24635271-7C5A13CF-C65F-4230-A340-855C3B1E9607Q24644811-6D92E949-EF19-4D6C-A11E-60EFED48EAB0Q24650331-E98961E1-520F-467D-95BF-E88E6BEC7E4AQ26752737-63A41B03-6F38-4463-88B7-7D2CB9FDF9B9Q27026000-AD67BE30-5A2E-4BC9-AAD5-FA40A08E7032Q27316022-B988F3FA-6542-4EBD-BDA1-1F297E4917B3Q27664759-270FA6D6-4FAB-4F78-8AE5-A7527C8DE650Q28384647-822B2AE3-0513-4059-82AB-318A170ED2D7Q28385995-C979EA96-7CBC-404C-963C-AA7AB6A10D97Q28535346-69EFDB00-3766-4434-90CB-3CB1A99E3A65Q28585561-7B3A5EBE-84BD-4883-9C71-426F7BD26519Q28595739-2F36312F-6139-4673-B4A8-2C3A1747EF86Q28659945-FD945731-932C-489E-8A9A-BDA78DB1373FQ29619540-B834DF86-B912-40C8-92DF-720DF5A8B58DQ30439948-61AE27D0-4F01-43BE-929D-AE9312F9DD83Q30519179-07C2B68A-CD1D-4ACA-8744-FC6B4E42A3A6Q30993115-F5B0BBB8-C152-4AA2-8AEF-80C95E34E2B2Q31034125-2CADC811-7AFB-4811-839E-3AFE05DAAB9CQ33369078-A349348D-DA52-481C-906E-CC0D3E120496Q33408799-9B3987DA-3A27-4FE1-B42C-255A6D60B502Q33450556-42A61AEC-0ED3-4C97-A691-8650613AF1ADQ33455505-323BE3FE-527A-473B-8D48-9E430CB4748BQ33528976-8DE29E89-CF7C-4888-BF12-5D64482DF6A6Q33564429-B5BD99E6-329B-420D-811F-E0169F7D304AQ33743176-94B124D8-729B-4C9B-87D3-6FF882360F29Q33807551-F1F80581-3F88-4665-AC05-EE90FC054365Q33861091-0D6DA330-378A-4ACC-B271-06CB1DFB3517
P2860
Quantitative membrane proteomics reveals new cellular targets of viral immune modulators
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Quantitative membrane proteomics reveals new cellular targets of viral immune modulators
@ast
Quantitative membrane proteomics reveals new cellular targets of viral immune modulators
@en
Quantitative membrane proteomics reveals new cellular targets of viral immune modulators.
@nl
type
label
Quantitative membrane proteomics reveals new cellular targets of viral immune modulators
@ast
Quantitative membrane proteomics reveals new cellular targets of viral immune modulators
@en
Quantitative membrane proteomics reveals new cellular targets of viral immune modulators.
@nl
prefLabel
Quantitative membrane proteomics reveals new cellular targets of viral immune modulators
@ast
Quantitative membrane proteomics reveals new cellular targets of viral immune modulators
@en
Quantitative membrane proteomics reveals new cellular targets of viral immune modulators.
@nl
P2093
P2860
P1433
P1476
Quantitative membrane proteomics reveals new cellular targets of viral immune modulators
@en
P2093
Ashley McCormack
Eric Bartee
Klaus Früh
P2860
P356
10.1371/JOURNAL.PPAT.0020107
P577
2006-10-01T00:00:00Z